Evidence map›Paper›PMID 32066718›Full record

ArticleTranslational psychiatry2020

On the relationship of first-episode psychosis to the amphetamine-sensitized state: a dopamine D

Ana Weidenauer, Martin Bauer, Ulrich Sauerzopf, Lucie Bartova, Lukas Nics, Sarah Pfaff, Cecile Philippe, Neydher Berroterán-Infante, Verena Pichler, Bernhard M Meyer and 17 more

Open access · goldAbstract read
In one paragraph

Article in Translational psychiatry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 38 citations in OpenAlex.

  1. Continuous infusion [European journal of nuclear medicine and molecular imaging · 2026
    Article
  2. Review
  3. Dopamine DPsychological medicine · 2025
    Article
  4. Article
  5. Review
  6. Article
  7. Observational
  8. Article
  9. Psychotomimetic compensation versus sensitization.Pharmacology research & perspectives · 2024
    Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Evaluation of dopamine DPsychopharmacology · 2021
    Article
  19. The High Affinity Dopamine DACS chemical neuroscience · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 4 institutions in 4 countries.

Ana Weidenauer *Department of Psychiatry and Psychotherapy, Division of General Psychiatry, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.
Martin Bauer *Department of Psychiatry and Psychotherapy, Division of General Psychiatry, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.
Ulrich SauerzopfDepartment of Psychiatry and Psychotherapy, Division of General Psychiatry, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.
Lucie BartovaDepartment of Psychiatry and Psychotherapy, Division of General Psychiatry, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.
Lukas NicsDepartment of Biomedical Imaging and Image Guided Therapy, Medical University of Vienna, Vienna, Austria.
Sarah PfaffDepartment of Biomedical Imaging and Image Guided Therapy, Medical University of Vienna, Vienna, Austria.
Cecile PhilippeDepartment of Biomedical Imaging and Image Guided Therapy, Medical University of Vienna, Vienna, Austria.
Neydher Berroterán-InfanteDepartment of Biomedical Imaging and Image Guided Therapy, Medical University of Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0002-9247-6457
Verena PichlerDepartment of Biomedical Imaging and Image Guided Therapy, Medical University of Vienna, Vienna, Austria.
Bernhard M MeyerDepartment of Psychiatry and Psychotherapy, Division of General Psychiatry, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.
Ulrich RablDepartment of Psychiatry and Psychotherapy, Division of General Psychiatry, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.
Patrick SezenDepartment of Psychiatry and Psychotherapy, Division of General Psychiatry, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.
Paul CummingSchool of Psychology and Counseling and IHBI, Queensland University of Technology, Brisbane, Australia.
Thomas StimpflDepartment of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
Harald H SitteInstitute of Pharmacology, Medical University of Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0002-1339-7444
Rupert LanzenbergerDepartment of Psychiatry and Psychotherapy, Division of General Psychiatry, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.ORCID http://orcid.org/0000-0003-4641-9539
Nilufar MossahebDepartment of Psychiatry and Psychotherapy, Division of Social Psychiatry, Medical University of Vienna, Vienna, Austria.
Alexander ZimprichDepartment of Neurology, Medical University of Vienna, Vienna, Austria.
Pablo RusjanResearch Imaging Centre, Centre for Addiction and Mental Health, University of Toronto, Toronto, Canada.
Georg DorffnerCenter for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, Vienna, Austria.
Markus MitterhauserDepartment of Biomedical Imaging and Image Guided Therapy, Medical University of Vienna, Vienna, Austria.
Marcus HackerDepartment of Biomedical Imaging and Image Guided Therapy, Medical University of Vienna, Vienna, Austria.
Lukas PezawasDepartment of Psychiatry and Psychotherapy, Division of General Psychiatry, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.ORCID http://orcid.org/0000-0002-1329-6352
Siegfried KasperDepartment of Psychiatry and Psychotherapy, Division of General Psychiatry, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.
Wolfgang WadsakDepartment of Biomedical Imaging and Image Guided Therapy, Medical University of Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0003-4479-8053
Nicole Praschak-RiederDepartment of Psychiatry and Psychotherapy, Division of General Psychiatry, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.
Matthäus WilleitDepartment of Psychiatry and Psychotherapy, Division of General Psychiatry, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria. matthaeus.willeit@meduniwien.ac.at.
Medical University of Vienna · ATCentre for Addiction and Mental Health · CALudwig Boltzmann Institute Applied Diagnostics · ATUniversity of Bern · CH

Funding

Austrian Science Fund FWF P 23585
6 · The paper itself

Abstract

Schizophrenia is characterized by increased behavioral and neurochemical responses to dopamine-releasing drugs. This prompted the hypothesis of psychosis as a state of "endogenous" sensitization of the dopamine system although the exact basis of dopaminergic disturbances and the possible role of prefrontal cortical regulation have remained uncertain. To show that patients with first-episode psychosis release more dopamine upon amphetamine-stimulation than healthy volunteers, and to reveal for the first time that prospective sensitization induced by repeated amphetamine exposure increases dopamine-release in stimulant-naïve healthy volunteers to levels observed in patients, we collected data on amphetamine-induced dopamine release using the dopamine D

Indexed as

Pharmaceutical PreparationsPsychotic DisordersAmphetamineDopamineFemaleHumansProspective StudiesAmphetamineDopaminePharmaceutical Preparations

Identifiers

PMID32066718
PMCPMC7026156
OpenAlexW2999828435

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.